Jacob Tanguay

1.6k total citations
11 papers, 66 citations indexed

About

Jacob Tanguay is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Jacob Tanguay has authored 11 papers receiving a total of 66 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Oncology. Recurrent topics in Jacob Tanguay's work include Prostate Cancer Treatment and Research (8 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Cancer Treatment and Pharmacology (4 papers). Jacob Tanguay is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Cancer Treatment and Pharmacology (4 papers). Jacob Tanguay collaborates with scholars based in United Kingdom. Jacob Tanguay's co-authors include J.F. Lester, M. Button, Nachi Palaniappan, Jessica Evans, Nicholas D. James, Satish Kumar, John Staffurth, Anjali Zarkar, J. Glaholm and Louise Hanna and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Thoracic Oncology.

In The Last Decade

Jacob Tanguay

11 papers receiving 63 citations

Peers

Jacob Tanguay
Andrew Protheroe United Kingdom
Robin Millman United Kingdom
Jaymala Patel United States
Danny Houtsma Netherlands
Joshua A. Urrutia United States
Kristen Cummings United States
Andrew Protheroe United Kingdom
Jacob Tanguay
Citations per year, relative to Jacob Tanguay Jacob Tanguay (= 1×) peers Andrew Protheroe

Countries citing papers authored by Jacob Tanguay

Since Specialization
Citations

This map shows the geographic impact of Jacob Tanguay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Tanguay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Tanguay more than expected).

Fields of papers citing papers by Jacob Tanguay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Tanguay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Tanguay. The network helps show where Jacob Tanguay may publish in the future.

Co-authorship network of co-authors of Jacob Tanguay

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Tanguay. A scholar is included among the top collaborators of Jacob Tanguay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Tanguay. Jacob Tanguay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
James, Nicholas D., Hannah Rush, Noel W. Clarke, et al.. (2020). 611O Abiraterone acetate plus prednisolone for hormone-naïve prostate cancer (PCa): Long-term results from metastatic (M1) patients in the STAMPEDE randomised trial (NCT00268476). Annals of Oncology. 31. S509–S509. 14 indexed citations
3.
Powell, Jane, Jim Barber, Jacob Tanguay, et al.. (2016). Assessment of the feasibility of using transrectal ultrasound for postimplant dosimetry in low-dose-rate prostate brachytherapy. Medical dosimetry. 41(4). 290–295. 2 indexed citations
4.
Tanguay, Jacob, et al.. (2016). 93P: Chemoradiotherapy with radical intent for small cell lung cancer (SCLC): A 5 year retrospective review. Journal of Thoracic Oncology. 11(4). S97–S97. 2 indexed citations
6.
Button, M., et al.. (2015). What Predicts Minimal Response to Abiraterone in Metastatic Castrate-resistant Prostate Cancer?. PubMed. 35(10). 5615–21. 3 indexed citations
7.
Tanguay, Jacob, et al.. (2015). What predicts minimal response to abiraterone in metastatic castrate resistant prostate cancer?. Journal of Clinical Oncology. 33(15_suppl). e16103–e16103. 2 indexed citations
8.
Stevenson, Robert B., Daniel Ford, J. Glaholm, et al.. (2014). The sequential use of abiraterone and enzalutamide in metastatic castrate resistant prostate cancer patients: Experience from seven U.K. centers.. Journal of Clinical Oncology. 32(4_suppl). 125–125. 11 indexed citations
9.
Evans, Jessica, M. Button, Satish Kumar, et al.. (2013). Time to prostate specific antigen (PSA) nadir may predict rapid relapse in men with metastatic castration-resistant prostate cancer (CRPC) receiving docetaxel chemotherapy. Medical Oncology. 30(4). 719–719. 15 indexed citations
11.
Ansari, Jawaher, Syed A. Hussain, Anjali Zarkar, et al.. (2008). Docetaxel re-treatment for metastatic hormone refractory prostate cancer. Journal of Clinical Oncology. 26(15_suppl). 16066–16066. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026